⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for metastatic squamous cell carcinoma of the oropharynx

Every month we try and update this database with for metastatic squamous cell carcinoma of the oropharynx cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Combination Chemotherapy With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and NeckNCT01064479
Metastatic Squa...
Metastatic Squa...
Metastatic Squa...
Metastatic Squa...
Recurrent Hypop...
Recurrent Laryn...
Recurrent Oral ...
Recurrent Oroph...
Stage IV Hypoph...
Stage IV Laryng...
Stage IV Oral C...
Stage IV Oropha...
Stage IVA Hypop...
Stage IVA Laryn...
Stage IVA Oral ...
Stage IVA Oroph...
Stage IVB Hypop...
Stage IVB Laryn...
Stage IVB Oral ...
Stage IVB Oroph...
Stage IVC Hypop...
Stage IVC Laryn...
Stage IVC Oral ...
Stage IVC Oroph...
Carboplatin
Cisplatin
Docetaxel
Erlotinib Hydro...
Laboratory Biom...
Pharmacological...
Placebo
Quality-of-Life...
18 Years - M.D. Anderson Cancer Center
Combination Chemotherapy With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and NeckNCT01064479
Metastatic Squa...
Metastatic Squa...
Metastatic Squa...
Metastatic Squa...
Recurrent Hypop...
Recurrent Laryn...
Recurrent Oral ...
Recurrent Oroph...
Stage IV Hypoph...
Stage IV Laryng...
Stage IV Oral C...
Stage IV Oropha...
Stage IVA Hypop...
Stage IVA Laryn...
Stage IVA Oral ...
Stage IVA Oroph...
Stage IVB Hypop...
Stage IVB Laryn...
Stage IVB Oral ...
Stage IVB Oroph...
Stage IVC Hypop...
Stage IVC Laryn...
Stage IVC Oral ...
Stage IVC Oroph...
Carboplatin
Cisplatin
Docetaxel
Erlotinib Hydro...
Laboratory Biom...
Pharmacological...
Placebo
Quality-of-Life...
18 Years - M.D. Anderson Cancer Center
Sorafenib in Combination With Carboplatin and Paclitaxel in Treating Participants With Metastatic or Recurrent Head and Neck Squamous Cell CancerNCT00494182
Metastatic Head...
Metastatic Squa...
Metastatic Squa...
Metastatic Squa...
Metastatic Squa...
Recurrent Head ...
Recurrent Hypop...
Recurrent Laryn...
Recurrent Oral ...
Recurrent Oroph...
Carboplatin
Paclitaxel
Sorafenib
18 Years - M.D. Anderson Cancer Center
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: